肿瘤心血管病学的循证临床实践  

Evidence-based Clinical Management in Cardio-oncology

作　　者：徐俊波 黄刚 蔡琳 余秀琼 刘汉雄 XU Junbo;HUANG Gang;CAI Lin;YU Xiuqiong;LIU Hanxiong(Department of Cardiology,The Third People’s Hospital of Chengdu,Chengdu Cardiovascular Disease Research Institute,Clinical College of Southwest Jiaotong University,The Second Affiliated Chengdu Clinical College of Chongqing Medical University,Chengdu 610031,Sichuan,China)

机构地区：[1]成都市心血管病研究所,成都市第三人民医院心血管内科,西南交通大学附属医院,重庆医科大学附属成都第二医院,四川成都610031

出　　处：《心血管病学进展》2020年第5期468-471,共4页Advances in Cardiovascular Diseases

基　　金：成都市科技局项目(2019-YF05-00523-SN,11PPYB034SF-289)。

摘　　要：肿瘤疾病和心血管疾病均是目前全球的重大疾病负担和挑战。预期寿命得到延长的肿瘤患者,罹患抗肿瘤治疗相关的心血管疾病的概率明显增加,作为多学科整合的肿瘤心血管病学方兴未艾。现着重介绍当前肿瘤心血管病学的临床管理实践策略,为广大临床医师提供参考。Cancer and cardiovascular disease are currently important disease-related burdens and challenges worldwide.Cancer therapeutics-related cardiovascular diseases become more commonly in cancer patients with longer expected life time than before.In this background,cardio-oncology is emerging as a multi-discipline in past decades.Here,we introduce the general management in clinical practice of cardio-oncology in this article,which may be helpful for physicians in daily practice.

关 键 词：肿瘤心血管病学 抗肿瘤治疗 心血管毒性 

分 类 号：R730.5[医药卫生—肿瘤] R54[医药卫生—临床医学]